Capromab Pendetide Immunoscintigraphy: Connecting the Dots for Prostate Cancer Imaging
- 1 April 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 15 (2) , 127-130
- https://doi.org/10.1089/cbr.2000.15.127
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancerUrology, 1999
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Practice Trends in the Diagnosis and Management of Prostate Cancer in the United StatesJournal of Urology, 1995
- RADIATION THERAPY FOR LOCAL RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMYUrologic Clinics of North America, 1994
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Two different lymph node metastatic patterns of a prostatic cancerCancer, 1990